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596Background: Previous studies suggest that mortality from congenital heart diseases (CHDs) is declining in the
United States. But we do not know what the CHD mortality trend is in China, especially the rural versus urban
patterns. Our study aimed to determine recent changes in death caused by CHD in China and describe CHD
mortality in rural and urban Chinese populations.
Methods: The data source was the China Ministry of Health 2003 to 2010 annual reports. Mortality was defined
as death caused by CHD. Mortality rates for each year were calculated per 10,000,000 person-years. Poisson
regression and descriptive analyses were conducted for overall trend and subgroup analysis was conducted
by sex, age, and urban versus rural residency to understand potential disparities in mortality.
Results: From 2003 to 2010, the overall mortality rate increased from 141 per 10,000,000 person-years in 2003
to 229 per 10,000,000 person-years in 2010, a 62.4% relative increase. This represents a region–sex adjusted
annual increase of 9% (incidence rate ratio, 1.09; 95% confidence interval, 1.09-1.10). The increase in CHD
mortality was not uniformly observed across age groups, urban versus rural residence, and sex. The relative
increases were 65.3%, 212.2%, and 131.7% for ages 1 to 10 years, 21 to 64 years, and 65 years or older groups,
respectively. Urban areas had a relative increase of 154.5% versus 5.3% for rural areas. Females who lived in an
urban environment had a relative increase of 313.5%.
Conclusions: Our observation showed an obvious increasing trend of CHD mortality in China. What is more,
the increase in CHD mortality was not uniformly observed across subgroups. Such information is needed for
strategy-making procedures. (J Thorac Cardiovasc Surg 2014;148:596-602)Supplemental material is available online.
Congenital heart disease (CHD) is the world’s most
common birth defect, affecting more than 1% of
newborns.1 Nearly 30% to 50% of birth defect mortality
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The Journal of Thoracic and Cardiovascular Surgmeasuring birth defect prevalence in the Chinese
population reported that CHD is among the top 3, with a
prevalence of 7 to 8 cases per 1000 live births,6 translating
into 100,000 to 150,000 new cases annually. However, in
China, there is also a growing trend of children with
CHD surviving to adulthood making the treatment and
management of CHD in older children and adults a growing
public health problem in China today.
As the world’s largest developing country, China is still
characterized by large rural–urban disparities in many areas
of health care.7,8 China’s accelerated rate of urbanization
has further exacerbated these disparities. However,
before our study there have been no reports available
describing CHD mortality in the Chinese rural and urban
populations, with the exception of several small-sized clin-
ical series. Although it has been posited that urban–rural
disparities exist in CHDmortality rates, our study is the first
to use a comprehensive data sample to answer this question.
In our study, we used age, sex, and cause-specific mortal-
ity data from the largest and longest-running Chinese health
registration system administered by the Chinese Ministry of
Health.9 This system samples about 10% of the Chinese
population, amounting to 100 million residents, from
different regions throughout China selected by the Chinese
Ministry of Health. We used only the 2003-2010 mortality
data because these data are coded in accordance with theery c August 2014
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(ICD-10). We then used these data to describe the temporal
changes and rural–urban disparities in Chinese CHD
mortality.
MATERIALS AND METHODS
Chinese Health Statistics, including multiple causes of death public-use
data files, are released annually by the Health Statistics and Information
Center, which is part of China’s Ministry of Health. These files come
from data collected from all death certificates issued for deaths occurring
around China. The data files sample about 10% of the Chinese population,
selected from affluent regions and surrounding suburban areas. In our
study, we analyzed CHD mortality trend from 2003 to 2010. During this
period, ICD-10 was used to identify mortality causes in the vital statistics,
and up to 20 conditions were listed as contributing causes of death.
In our study, those with CHD listed as the underlying or contributing
cause were considered as deaths resulting from CHD. The denominators
for mortality rates were the national population estimates or census data
(the year 2000) released from the National Bureau of Statistics of China
(http://www.stats.gov.cn/tjsj/ndsj/). We used the national population
information from the previous year as CHD mortality denominators. To
account for the different age compositions among subpopulations, we
adjusted the overall, rural- or urban-specific, and sex-specific mortality
rate by applying the age-specific mortality rates to the population
information of the previous year. For example, as for the CHD mortality
of 2004, we used population estimates of 2003 as the denominators; also,
we used the 2003 sex and age structures to adjust the CHD mortality of
2004. Annual age-specific CHD death rates were calculated per
10,000,000 population among the following age groups:<1 year, 1 to
10 years, 11 to 20 years, 21 to 64 years, and>65 years, stratified by sex
and rural/urban areas.
We assessed the trend in the mortality rates during the study period. We
then fitted a generalized linear mixed effects model with a Poisson link
function, adjusting for age–sex, annual gross domestic product, health
care workers per 100,000 population, and physician-to-nurse ratio. The
total person-years (at the log scale) was used as an offset in the model to
obtain the expected numbers of deaths. The time (year) was modeled as
an ordinal time variable, ranging from 0 to 7, corresponding to years
2003 (Time ¼ 0) to 2010 (Time ¼ 7), to represent the annual change in
CHD-specificmortality. We estimated the risk-adjusted incidence rate ratio
and its corresponding 95% confidence interval [CI] in each subsequent
analysis.
All statistical testing was 2-sided, at a significance level of 0.05,
and all analyses were carried out using SAS version 9.3 64-bit version
(SAS Institute Inc, Cary, NC). The authors had full access to and take
full responsibility for the integrity of the data. The Fuwai Hospital
Institutional Review Board reviewed and approved the study.
RESULTS
According to Chinese Health Statistics, deaths among
Chinese citizens were steadily rising from 591.1 per
100,000 population in 2003 to 621.2 per 100,000 population
in 2010. Death associated with CHD accounted for around
0.2% of total deaths in both years, overall CHD mortality
increased by 62%, from 141 to 229 per 10 million (Table 1).The Journal of Thoracic and CaCHD Mortality by Areas and by Sex
CHD mortality in urban areas increased significantly
from 121 to 308 deaths per 10 million, but only moderate
increases were observed in rural areas (Table 1 and
Figure 1). Mortality increased among both male and female
individuals, but the trend in females was larger, with an
increase of 127% from 124 to 282 per 10 million
(Table 1 and Figure 2). What is more, we saw an increasing
mortality trend among urban females from 111.0 to 459.0
per 10 million and a decreasing trend from 131 to 127 per
10 million in rural females (Table 1).CHD Mortality by Age Groups
We observed a reverse J-shaped pattern of age-specific
mortality associated with CHD. Mortality was highest
among infants and lowest among citizens older than age
65 years. The proportion of mortality among adults older
than age 20 years changed from 21% in 2003 to 45% in
2010.Infant Mortality
Infant mortality accounted for 41.2% of all mortality-
associated CHD. There was an increasing trend of overall
infant mortality associated with CHD before 2007 and a
slight drop since then. Throughout the study period,
CHD-associated mortality in infants was 7585.5 per 10
million. Overall infant mortality was 5803.9 per 10 million,
peaked to 7960.8 10 million in 2007, and dropped to 7470.6
10 million in 2010. After 2005, the urban population had a
higher mortality associated with CHD in infants than the
rural population (Figure 3, A). Furthermore, the adjusted
age time interaction term was associated with higher
mortality, indicating an increase of peak mortality age
(Table 2).Child Mortality
Among children aged 1 to 10 years, mortality associated
with CHD increased 65.3% overall and 8.2% annually.
Among the urban and rural populations, mortality
associated with CHD increased 15.8% and 109.1%,
respectively (Figure 3, B).
Among children aged 11 to 20 years, mortality associated
with CHD did not change significantly. Throughout
the study period, mortality associated with CHD was
higher among rural than among urban individuals in this
population, except during 2003 and 2007 (Figure 3, C).
Overall, mortality among children who survived the first
year of life accounted for 28.4% of all mortality associated
with CHD.Adult Mortality
Among adults aged 21 to 64 years, mortality associa-
ted with CHD increased by 212.2%. This increaserdiovascular Surgery c Volume 148, Number 2 597
TABLE 1. Trend in congenital heart disease mortality in China, by year
Measure
Year
2003 2004 2005 2006 2007 2008 2009 2010
Overall population
Population 1,239,612,226 1,283,604,890 1,297,166,669 1,305,781,632 1,314,956,999 1,320,825,559 1,328,661,780 1,333,782,508
Deaths,* n 17,424 19,269 16,092 19,272 24,916 21,105 22,292 30,520
Mortalityy
(95% CI)
141.0
(138.5-142.7)
150.0
(148.0-152.3)
124.0
(122.2-126.0)
148.0
(145.5-149.7)
189.0
(187.1-191.9)
160.0
(157.6-162.0)
168.0
(165.6-170.0)
229.0
(226.3-231.4)
Females
Population 599,336,257 628,411,406 637,573,500 642,957,285 648,691,289 651,113,337 654,095,826 656,487,972
Deaths,* n 7416 8771 7357 8088 10,516 9209 9344 18,498
Mortalityy
(95% CI)
124.0
(120.9-126.6)
140.0
(136.7-142.5)
115.0
(112.8-118.1)
126.0
(123.1-128.6)
162.0
(159.0-165.2)
141.0
(138.6-144.4)
143.0
(140.0-145.8)
282.0
(277.7-285.9)
Males
Population 640,275,969 655,193,484 659,593,169 662,824,347 666,265,710 669,712,222 674,565,954 677,294,536
Deaths,* n 10,008 10,497 8735 11,184 14,400 11,895 12,948 12,022
Mortalityy
(95% CI)
156.0
(153.3-159.4)
160.0
(157.2-163.3)
132.0
(129.7-135.2)
169.0
(165.6-171.9)
216.0
(212.6-219.7)
178.0
(174.4-180.8)
192.0
(188.7-195.3)
178.0
(174.3-180.7)
Urban area
Overall population
Population 455,770,983 519,859,981 542,215,668 559,188,845 577,266,123 593,050,676 607,198,434 621,180,613
Deaths,* n 5514 8249 4654 8542 13,151 11,217 10,335 19,120
Mortalityy
(95% CI)
121.0
(117.8-124.2)
159.0
(155.3-162.1)
86.0
(83.4-88.3)
153.0
(149.5-156.0)
228.0
(223.9-231.7)
189.0
(185.7-192.7)
170.0
(166.9-173.5)
308.0
(303.5312.2)
Urban area
Females
Population 220,506,276 254,506,620 266,505,724 275,352,847 284,775,476 292,349,888 298,921,793 305,923,396
Deaths,* n 2451 3823 1847 3630 5540 5236 4295 14,029
Mortalityy
(95% CI)
111.0
(106.8-115.7)
150.0
(145.5-155.1)
69.0
(66.2-72.6)
132.0
(127.6-136.2)
195.0
(189.5-199.7)
179.0
(174.3-184.0)
144.0
(139.4-148.1)
459.0
(451.0-466.2)
Urban area
Males
Population 235,264,707 265,353,361 275,709,944 283,835,998 292,490,647 300,700,788 308,276,641 315,257,217
Deaths,* n 3063 4426 2806 4912 7611 5981 6040 5091
Mortalityy
(95% CI)
130.0
(125.6-134.9)
167.0
(161.9-171.8)
102.0
(98.1-105.6)
173.0
(168.3-178.0)
260.0
(254.4-266.1)
199.0
(193.9-204.0)
196.0
(191.0-200.9)
161.0
(157.1-166.0)
Rural area
Overall population
Population 783,841,243 763,744,909 754,951,001 746,592,787 737,690,876 727,774,883 721,463,346 712,601,895
Deaths,* n 11,910 11,020 11,438 10,730 11,765 9888 11,957 11,400
Mortalityy
(95% CI)
152.0
(149.2-154.7)
144.0
(141.6-147.0)
152.0
(148.8-154.3)
144.0
(141.0-146.5)
159.0
(156.6-162.4)
136.0
(133.2-138.6)
166.0
(162.8-168.7)
160.0
(157.1-163.0)
Rural area
Females
Population 378,829,981 373,904,786 371,067,776 367,604,438 363,915,813 358,763,449 355,174,033 350,564,576
Deaths,* n 4965 4948 5509 4458 4976 3973 5049 4469
Mortalityy
(95% CI)
131.0
(127.4-134.8)
132.0
(128.7-136.1)
148.0
(144.6-152.5)
121.0
(117.7-124.9)
137.0
(133.0-140.6)
111.0
(107.3-114.2)
142.0
(138.3-146.1)
127.0
(123.8-131.3)
Rural area
Males
Population 405,011,262 389,840,123 383,883,225 378,988,349 373,775,063 369,011,434 366,289,313 362,037,319
Deaths,* n 6945 6071 5929 6272 6789 5914 6908 6931
Mortalityy
(95% CI)
171.0
(167.5-175.6)
156.0
(151.9-159.7)
154.0
(150.5-158.4)
165.0
(161.4-169.6)
182.0
(177.3-186.0)
160.0
(156.2-164.4)
189.0
(184.2-193.1)
191.0
(187.0-196.0)
CI, Confidence interval. *Deaths due to congenital heart diseases. yObserved mortality from congenital heart diseases, represented in mortality per 10 million population.
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FIGURE 1. Observed trend in congenital heart disease (CHD) mortality
by city and rural residence from 2003 to 2010 (per 10,000,000
person-years) The red þ symbols represent CHD mortality rate in urban
areas each year. The green3 symbols represent CHDmortality rate in rural
areas each year. Blue circles represent the overall CHD mortality rate each
year. The red dashed line represents regression curve of CHDmortality rate
in urban areas, whereas the red shadow represents its 95% confidence
interval. The green dashed line represents regression curve of CHD
mortality rate in urban areas, and the green shadow represents its 95%
confidence interval. The blue solid line represents the regression curve of
overall CHD mortality.
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urban population. CHD mortality among rural popula-
tion remained stable throughout the study period
(Figure 3, D).
Among adults aged65 years, we observed a rising trend
of mortality associated with CHD over the study period.
Again, the urban population mortality rate increasedFIGURE 2. Observed trend in congenital heart disease (CHD)
mortality by sex from 2003 to 2010 (per 10,000,000 person-years)
The red þ symbols represent CHD mortality rate among men each year.
The blue circles represent CHD mortality rate among women each year.
The red dashed line represents the regression curve of CHD mortality
rate in urban areas, and the red shadow represents its 95% confidence
interval. The blue solid line represents the regression curve of overall
CHD mortality, and the blue shadow represents its 95% confidence
interval.
The Journal of Thoracic and Cadramatically, and accounted for much of the overall
increase. (Figure 3, E).
Trends After Adjustment
After adjusting for demographic and economic variables,
time was still associated with increasing mortality
(odds ratio [OR], 1.09; 95% CI, 1.08-1.10). After
adjustment, being a female, increased age, and living in a
city were associated with low mortalities (Table 3).
Additionally, mortality in urban areas increased
over time (city–time interaction, OR, 1.15; 95% CI,
1.14-1.15). Overall mortality in females decreased over
time (female–time interaction: OR, 0.99; 95% CI,
0.99-0.99), but mortality in urban females increased from
2003 to 2010 (Table 2). The age–time interaction term
was associated with higher mortality (OR, 1.04; 95%
CI, 1.04-1.05), indicating a slight increase in age of death.
DISCUSSION
A knowledge of a country’s mortality patterns is essential
to understand a country’s public health needs and properly
implement public health programs. However, China’s CHD
monitoring system is incomplete, making it difficult to
document temporal changes in mortality rates. Moreover,
China’s rapid urbanization during the past few decades10
has widened the rural–urban gap and heavily influenced
many health outcomes. Yet, before our study no data had
been available to describe rural/urban disparities in CHD
mortality rates.
Our study, which analyzed data from the largest and
longest running Chinese health registration system, is the
first to depict the temporal trend and the rural–urban
disparities of Chinese CHD mortality. It could also offer
an interesting platform in exploring health equity and
access to health care in a developing country. In our study
we found that the rate of change of CHD mortality in
urban areas, when compared with those in rural areas,
significantly increased over time; although most CHD-
related deaths still occur when a patient is aged<1 year,
this pattern has changed between 2003 and 2010; and
CHD mortality rates of females living in urban areas have
increased significantly over time, whereas CHD mortality
rates of females living in rural areas have slightly decreased.
Previous reports have shown that there has been a decline
in CHD mortality in the American, English, and Canadian
populations during the past 3 decades.11-14 However, in
our study, we observed an increasing trend of CHD
mortality in the Chinese population. There are several
potential reasons for this trend. Compared with
developed countries, patients with CHD in China have
relatively limited access to diagnosis and treatment.
However, treatment has improved in recent years.
After implementing a fetal echocardiography training
program, a rising CHD detection rate was observed in ardiovascular Surgery c Volume 148, Number 2 599
FIGURE 3. Observed trend in congenital heart disease mortality by different age intervals (A,<1 year old; B, 1-10 years old; C, 11-20 years old; D, 21-64
years old; D,65 years old) from 2003 to 2010 (per 10,000,000 person-years). The redþ symbol represents congenital heart disease (CHD) mortality rate in
urban areas each year. The green3 symbol represents CHDmortality rate in rural areas each year. The blue circles represent the overall CHDmortality rate
each year. The red dashed line represents regression curve of CHDmortality rate in urban areas, and the red shadow represents its 95% confidence interval.
The green dashed line represents the regression curve of CHD mortality rate in urban areas, and the green shadow represents its 95% confidence interval.
The blue solid line represents the regression curve of overall CHD mortality, and the blue shadow represents its 95% confidence interval.
TABLE 3. Affect of city or rural residence, sex, age, and time on
mortality in China
Outcomes Odds ratio 95% Confidence interval
Unadjusted
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CHD incidence at birth and therapeutic termination of
pregnancy.15 Nationwide, a hospital-based birth defect
monitoring system in China reports that the prevalence of
CHD almost quintupled between 1996 and 2009.16 And
there is substantially similar pattern of CHD subsets
between China and North America.17,18 The increasing
prevalence of CHD at birth could partly explain the
growing trend of CHD mortality. What is more, a risingTABLE 2. Affect of time interaction on mortality in China
Outcomes
Odds ratio over
trend of time 95% Confidence interval
Unadjusted
Females 1.00 0.99-1.01
Urban 1.04 1.04-1.05
Age* 1.03 1.03-1.04
Urban 1.10 1.10-1.11
Adjustedy
Females 0.99 0.99-0.99
Urban 1.15 1.14-1.15
Age* 1.04 1.04-1.05
Urban 1.09 1.09-1.10
*In 5-year age group. yAdjusted for age and sex, annual gross domestic product,
health care workers per 100,000 population, and physician-to-nurse ratio.
600 The Journal of Thoracic and Cardiovascular SurgCHD detection rate could not only be observed in infants
and children but also in adults due to the improved access
to medical care during the study period, especially for
those with relatively mild congenital heart malformationDemographic
Female 0.99 0.99, 1.01
Age* 0.62 0.62, 0.62
Geographic
Urban 1.20 1.18, 1.21
Trend over time
Annual change 1.09 1.08, 1.09
Adjustedy
Demographic
Female 0.90 0.90, 0.91
Age* 0.67 0.67, 0.67
Geographic
Urban 0.91 0.90, 0.92
Trend over time
Annual change 1.09 1.08, 1.10
*In 5-year age group. yAdjusted for age and sex, annual gross domestic product,
health care workers per 100,000 population, and physician-to-nurse ratio.
ery c August 2014
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The growing CHD detection rate may contribute to a
significant increase of CHD mortality. However, this may
reflect a fake increase in mortality, reflecting instead a
real increase in diagnostic rate. Although reported deaths
certainly seem to be increasing, there is not sufficient
evidence to show that the prognosis of diagnosed CHD is
deteriorating in China.
The observed CHD mortality rate in urban areas
increased significantly faster than the rate in rural areas,
almost tripling from 121 per 10 million person-years
in 2003 to 309 per 10 million person-years in 2010.
One possible explanation is the dramatic differences in
access to health care resources in urban and rural areas.19
Previous studies have demonstrated that different payer
status influences access to health care resources among
patients with CHD. In the United States, a study analyzing
9656Medicaid patients20 found that Medicaid patients have
a higher risk of death compared with commercial insurance
or managed care patients. In China, rapid urbanization
intensifies inequalities of access to health care, both
between rural and urban areas19 and within urban areas.21
Because of accelerated economic growth and a 1984
decision to broaden the criteria for what constitutes a
‘‘city’’ or ‘‘town,’’22 large numbers of surplus agricultural
workers have continuously migrated into urban areas and
become classified as urban residents. However, although
officially urbanized, the majority of these workers have a
low socioeconomic status and have limited access to health
care. As a result, this growing proportion of the migrant
population may have contributed to the CHD mortality
increase in urban areas. Previously, we explained the rise
in CHD mortality in the general Chinese population by
improvement in CHD detection rates. The CHD detection
rates may increase more obviously in urban areas due to
better health care resources, thus explaining the rapid
increase of CHD mortality in urban areas.
In our study, the observed city mortality was lower than
rural rates at the beginning of the century but surpassed
rural rates during 2005, whereas after adjustment city
residence was significantly associated with a lower CHD
mortality rate, which is consistent with results from the
Congenital Corvitia study in The Netherlands.23 This
finding may reflect the overall advantages of the health
care delivery system in urbanized areas comparedwith those
in rural areas. Urbanization has deeply affected China’s
health care delivery system.24 To some degree, urbanization
improves health care quality, especially for cardiovascular
diseases.25 The treatment of CHD is a specialized area of
cardiology requiring specific expertise. Previous studies
demonstrated that better CHD treatment outcomes occurred
in hospitals with expertise in CHD treatment and high
volume26,27 conditions that occur more frequently in urban
areas. Differing rates of CHD mortality has also beenThe Journal of Thoracic and Caobserved in different socioeconomic groups, and in groups
with different access to medical care.
Consistent with previous reports among other
populations,12 our study showed that a larger proportion
of CHD deaths now occur in adults. Although children
have the highest CHD mortality rate, we observed slight
mortality declines in this group. This trend is mainly driven
by children younger than age 1 year and children between
ages 10 and 20 years. The Tomorrow Program, developed
by the Chinese government to improve health care access
for poor families, has improved specialty care28 and
increased public awareness and support for children with
CHD, which may have contributed to the mortality decline
among children within Chinese society. In our study, we
found that mortality occurred earlier among Chinese rural
citizens, with mortality rising in the age 1 to 10 years age
interval but declining among all other age groups. However,
among Chinese urban citizens a rising mortality trend was
observed throughout adulthood. Attention should be drawn
to changing mortality rates in specific age groups to build
efficient health services targeting these populations in the
future.
We found that the CHD mortality rate among urban
women also increased significantly over time. The improve-
ment of CHD detection rate may be 1 reason because
women tended to have less access to medical care in the
past. By the end of 2010, the female population in urban
areas was reported to be 0.7 billion, accounting for some
48.7% of the total Chinese population.10 Because the
number of urban women has increased dramatically during
the past couple of decades, if the CHD occurrence rate and
sex ratio among CHD patients remains unchanged, the
increasing CHD mortality rate will lead to a growing rate
of absolute CHD mortality among women in the future.
This trend will deeply influence the absolute numbers and
sex distribution of patients with CHD.
Our results may provide policy makers in Chinese public
health departments with first-hand material. Because city
dwelling is associated with lower CHD mortality according
to our results, outreach to rural areas should be enhanced.
And all females living in urban areas should have regular
screening to slow the rise we observed.
This research has several limitations: first, although a
death certificate signed by a physician is required by law
to report and record any cause of death, China does not
have a complete nationwide death registration system. As
a result, we could only obtain data from Chinese Health
Statistics, which measures approximately 10% of the
population from selected urban and rural areas. In these
data, large cities and surrounding areas were more likely
to be included in the registry; thus, the data are not
representative of the general population in China. However,
after comparing the total death rate between the death
registry data and national census data, we found that therdiovascular Surgery c Volume 148, Number 2 601
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throughout subgroups (ie, urban males, urban females, rural
males, and rural females; see Figure E1). Actually, the sys-
tem does provides data from>100 million residents in areas
with relatively good reporting and classification mecha-
nisms, which helps ensure data quality. Second, we did
not look at the CHD mortality trend before 2003 because
the death coding system changed from ICD 9 to ICD 10
in 2002. Without data before 2003, we cannot measure
long-term mortality trends. Third, CHD is a big diagnosis
group, including various disease subtypes. However, due
to lack of data, we could neither provide a breakdown of
the frequency of each disease subtype nor provide the mor-
tality trend of each major subtype. More precise studies will
rely on a more comprehensive and representative surveil-
lance system; however, our study was as precise as possible
using the data available. Third, the definition of urban and
rural varies over different nations. Our conclusions on ur-
ban/rural disparity in a Chinese population may not apply
to foreign populations. But this is the only geographic infor-
mation available from our data.
CONCLUSIONS
In our study, we examined the CHD mortality trend in
China during the past 8 years, with a particular emphasis
on the urban–rural disparities in CHD prevalence and
mortality. We found that the overall CHD mortality
rate in cities, compared with rural areas, increased
significantly from 2003 to 2010. The mortality rate among
urban-dwelling females has also increased significantly.
The average age of death from CHD has increased during
this same period of time, possibly driven by improvements
in health care quality. Although our study has several
limitations, it is the largest study focusing on CHD
mortality in a large population-based Chinese sample using
a comprehensively validated risk adjustment tool. Such
information is needed as a basis for working out and
evaluating interventions and for the ongoing monitoring
of CHD mortality and allocation of health care resources
to properly treat patients with CHD.
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FIGURE E1. All-cause mortality in a Chinese population. Comparison between death registry and population census. A, Urban males. B, Urban females.
C, Rural males. D, Rural females.
Hu et al Congenital Heart Disease
C
H
DThe Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 2 602.e1
